|
4D Robust Optimization in Intensity-Modulated Proton Therapy
|
1K25CA168984-01
|
$125,174
|
Liu, Wei
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
A Genetic Screen for HCC Genes
|
5R01CA132962-03
|
$302,919
|
LARGAESPADA, DAVID
|
UNIVERSITY OF MINNESOTA
|
|
A Multidisciplinary and Translational Approach to Hepatobiliary Malignancy
|
5K24CA139570-03
|
$186,940
|
Nelson, David
|
UNIVERSITY OF FLORIDA
|
|
A Needle Guidance System for Hepatic Tumor Ablation That Fuses Real-Time Ultrasou
|
2R44CA143234-02A1
|
$652,814
|
Razzaque, Sharif
|
INNEROPTIC TECHNOLOGY, INC.
|
|
A New Method for Improved Targeting in Image-guided Abdominal Interventions
|
5R01CA138586-03
|
$359,276
|
Hata, Nobuhiko
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
A novel diagnostic biomarker for hepatocellular carcinoma and cholangiocarcinoma
|
1R43CA165314-01A1
|
$292,459
|
Lu, Xuanyong
|
IMCARE BIOTECH
|
|
A Randomized Trial of Hep B Screening and Vaccination in High Risk Vietnamese
|
5R01CA129763-06
|
$477,672
|
MA, GRACE
|
TEMPLE UNIVERSITY
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,258,475
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Aberrant DNA Methylation of MicroRNA Genes in Hepatocellular Carcinoma (HCC)
|
5R03CA156629-02
|
$80,000
|
Shen, Jing
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Aberrantly secreted glycoproteins as markers of liver cancer
|
1U01CA168856-01
|
$293,548
|
Mehta, Anand
|
Drexel University
|
|
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse
|
1R01CA161694-01A1
|
$292,725
|
SELL, STEWART
|
WADSWORTH CENTER
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
3U01CA121947-05S1
|
$450,000
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
5U01CA121947-06
|
$6,010,333
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
Alliance of Glycobiologists for Detection of Cancer
|
1U01CA168926-01
|
$387,871
|
GOLDMAN, RADOSLAV
|
GEORGETOWN UNIVERSITY
|
|
An Orthotopic Murine Model of HCC: Immunotolerance and Prevention
|
1R01CA164335-01A1
|
$308,449
|
StaveleyO'Carroll, Kevin
|
PENNSYLVANIA STATE UNIVERSITY
|
|
Analysis of a novel regulator of hepatocellular carcinoma
|
3R01CA138540-03S1
|
$56,355
|
SARKAR, DEVANAND
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Analysis of a novel regulator of hepatocellular carcinoma
|
5R01CA138540-03
|
$300,907
|
SARKAR, DEVANAND
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Analysis of LC-MS data to identify peptide and glycan biomarkers for hepatocellul
|
5R01CA143420-03
|
$278,062
|
RESSOM, HABTOM
|
GEORGETOWN UNIVERSITY
|
|
ANC12006-001-00000 DIET INDUCED HYPOMETHYLATION IN THE PRE-NEOPLASTIC LIVER
|
Y01CN129006
|
$80,000
|
UNKNOWN, UNKNOWN
|
U.S. FOOD AND DRUG ADMINISTRATION
|
|
Antibody Therapy of Cancer
|
ZIABC010891
|
$518,195
|
Ho, Mitchell
|
CCR (NCI)
|
|
Aptamer targeting of osteopontin in hepatocellular cancer
|
1R21CA155306-01A1
|
$195,098
|
KUO, PAUL
|
LOYOLA UNIVERSITY CHICAGO
|
|
Asian Community Cancer Health Disparities Center (ACCHDC)
|
3U54CA153513-03S1
|
$50,000
|
MA, GRACE
|
TEMPLE UNIVERSITY
|
|
Asian Community Cancer Health Disparities Center (ACCHDC)
|
5U54CA153513-03
|
$960,300
|
MA, GRACE
|
TEMPLE UNIVERSITY
|
|
Asymmetric Division and Self Renewal of Cancer Stem Cells
|
ZIABC011003
|
$103,265
|
Avital, Itzhak
|
CCR (NCI)
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,176,890
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Atlases to Report and Correlate Radiotherapy Dose Distributions with Outcomes
|
5R01CA129182-04
|
$435,472
|
Jackson, Andrew
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIGBC010856
|
$14,609,987
|
Custer, Mary
|
CCR (NCI)
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIABC010030
|
$806,557
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biomarker Discovery for Hepatitis C Progression using Machine Learning Techniques
|
5K25CA127524-05
|
$133,197
|
Spratt, Heidi
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
Biomarkers of Opisthorchis viverrini-induced cholangiocarcinoma
|
5R01CA155297-02
|
$521,314
|
Brindley, Paul
|
GEORGE WASHINGTON UNIVERSITY
|
|
Biosynthesis of Selenocysteine and Its Incorporation into Protein
|
ZIABC010767
|
$160,128
|
Hatfield, Dolph
|
CCR (NCI)
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
ZIABC011004
|
$154,897
|
Avital, Itzhak
|
CCR (NCI)
|
|
BRIT1, A NOVEL HEPATOCELLULAR CARCINOMA TUMOR SUPPRESSOR
|
5R21CA161513-02
|
$171,064
|
LI, KAIYI
|
BAYLOR COLLEGE OF MEDICINE
|
|
CALGB Member Site: University of California - San Francisco
|
3U10CA138561-03S1
|
$106,497
|
Ryan, Charles
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
Cancer and Leukemia Group B
|
3U10CA031946-31S1
|
$114,228
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA031946-31
|
$7,759,618
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA032291-31
|
$495,751
|
Burstein, Harold
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer and Leukemia Group B
|
5U10CA047577-25
|
$99,190
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
Cancer and Leukemia Group B
|
3U10CA077597-14S1
|
$77,984
|
Liu, Minetta
|
GEORGETOWN UNIVERSITY
|
|
Cancer and Leukemia Group B
|
5U10CA077651-15
|
$212,393
|
Hudis, Clifford
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Cancer and Leukemia Group B
|
5U10CA041287-27
|
$258,606
|
KINDLER, HEDY
|
UNIVERSITY OF CHICAGO
|
|
Cancer and Leukemia Group B
|
5U10CA047559-22
|
$134,116
|
SHEA, THOMAS
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer and Leukemia Group B - Leukemia Correlative Sciences
|
5U10CA101140-10
|
$806,740
|
MARCUCCI, GUIDO
|
OHIO STATE UNIVERSITY
|
|
Cancer and Leukemia Group B - The Ohio State University
|
5U10CA077658-15
|
$487,632
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-27S1
|
$405,901
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-28
|
$2,286,202
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B Statistical Center
|
5U10CA033601-34
|
$4,701,770
|
SARGENT, DANIEL
|
MAYO CLINIC
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|